- Brachytherapy, a form of radiotherapy where a sealed radioactive source is placed inside or next to the area requiring treatment, is an effective cancer treatment that delivers a high dose of radiation to a small area
- The demand for brachytherapy is primarily fueled by its advantages, such as precise dose delivery, reduced treatment time, and fewer side effects compared to external beam radiation therapy, along with increasing cancer prevalence and a growing preference for minimally invasive treatments
- North America dominates the brachytherapy market with the largest revenue share of 38 92% in 2025, characterized by early adoption of advanced brachytherapy technologies, high healthcare expenditure, and a strong presence of key industry players and well-established cancer treatment centers
- Asia-Pacific is expected to be the fastest-growing region in the Brachytherapy market during the forecast period due to increasing healthcare infrastructure, rising cancer burden, and growing medical tourism
- The High-Dose Rate (HDR) Brachytherapy segment is expected to dominate the Brachytherapy market with a market share of 45 71% in 2025, driven by its established efficacy, flexibility in treatment planning, and convenience of outpatient procedures
